SMSPHARMANSE11 February 2022

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference call'.

SMS Pharmaceuticals Limited

~ sms

Pharmaceuticals Limited

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel: +91-40-25259999, Fax: +91-40-25259889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

Listing / Compliance Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor, Plot No. C-l, Block G, Bandra-Kurla Complex, Bandra (East), Mumbai- 400051

Date: February 11, 2022

To, Listing / Compl iance Departm ent BSE Limited Phiroze Jeejeebhoy Towers Dala l Street, Mumbai - 400 001

BSE Code: - 532815

NSE Code: SM SPHARMA

Ref: Regulation 30(6) of SEBI (LODR) Regulations, 2015

Sub: Intimation of Conference Call

Dear Sir/Madam,

This is to inform you that Conference Call for the Investors and Analysts has been scheduled on Friday,

February 18, 2022 at 11:00 AM 1ST to discuss the Company's financial performance for the Quarter and

nine-months ended December 31, 2021. Please find attached herewith the invitation for the same. Kindly

take the same on record.

Thanking you.

Yours Faithfully,

For SMS Pharmaceuticals Limited

~

Mr. V. S. Venkatish

Company Secretary & Compliance Officer

M. No: A21785

SMS Pharmaceuticals Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter and Nine-months ended 31st December, 2021

Day/Date: Friday, 18th February, 2022 Time: 11:00 AM, IST

Diamond Pass: Please Click here to express join the Call

Primary Number:

Toll Free Number:

+91 22 6280 1309 +91 22 7115 8210 Hongkong – 800964448 Singapore – 8001012045 UK – 08081011573 US – 18667462133

Participants:

Mr. Vamsi Krishna Potluri: Executive Director Mr. Lakshmi Narayana Tammineedi : Chief Financial Officer

We look forward to your participation

RSVP Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296

← All TranscriptsSMSPHARMA Stock Page →